JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: Similarly to BCR::ABL1/JAK2 double-positive cases, even in patients carrying both BCR::ABL1 and CALR, CML was easily managed with a good response to different types of TKIs.